DE10301917B4 - Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren - Google Patents

Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren Download PDF

Info

Publication number
DE10301917B4
DE10301917B4 DE10301917A DE10301917A DE10301917B4 DE 10301917 B4 DE10301917 B4 DE 10301917B4 DE 10301917 A DE10301917 A DE 10301917A DE 10301917 A DE10301917 A DE 10301917A DE 10301917 B4 DE10301917 B4 DE 10301917B4
Authority
DE
Germany
Prior art keywords
psoriasis
treatment
substances
acid
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10301917A
Other languages
German (de)
English (en)
Other versions
DE10301917A1 (de
Inventor
Gerhard Saalmann
Peter Saalmann
Hagen Prof. Dr. med. Tronnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medlight 32051 Herford De GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10301917A priority Critical patent/DE10301917B4/de
Application filed by Individual filed Critical Individual
Priority to AT03815354T priority patent/ATE479431T1/de
Priority to DE50313052T priority patent/DE50313052D1/de
Priority to EP03815354A priority patent/EP1583525B1/de
Priority to AU2003300499A priority patent/AU2003300499A1/en
Priority to PT03815354T priority patent/PT1583525E/pt
Priority to US10/542,355 priority patent/US20070099878A1/en
Priority to SI200331911T priority patent/SI1583525T1/sl
Priority to ES03815354T priority patent/ES2351971T3/es
Priority to JP2004566721A priority patent/JP2006514072A/ja
Priority to RU2005127035/15A priority patent/RU2336078C2/ru
Priority to PCT/DE2003/004254 priority patent/WO2004064827A1/de
Priority to DK03815354.0T priority patent/DK1583525T3/da
Publication of DE10301917A1 publication Critical patent/DE10301917A1/de
Application granted granted Critical
Publication of DE10301917B4 publication Critical patent/DE10301917B4/de
Priority to CY20101101103T priority patent/CY1110957T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE10301917A 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren Expired - Fee Related DE10301917B4 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE10301917A DE10301917B4 (de) 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
RU2005127035/15A RU2336078C2 (ru) 2003-01-17 2003-12-23 Применение веществ синтеза порфиринов для применения в фототерапии, а также для лечения заболеваний кожи и/или суставов
EP03815354A EP1583525B1 (de) 2003-01-17 2003-12-23 Verwendung einer kombination von substanzen der porphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen
AU2003300499A AU2003300499A1 (en) 2003-01-17 2003-12-23 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
PT03815354T PT1583525E (pt) 2003-01-17 2003-12-23 Utilização de uma combinação de substâncias da síntese de porfirina, salicilatos e anti-oxidantes na fototerapia de doenças da pele e/ou das articulações
US10/542,355 US20070099878A1 (en) 2003-01-17 2003-12-23 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
SI200331911T SI1583525T1 (sl) 2003-01-17 2003-12-23 Uporaba kombinacije snovi porfirinske sinteze, salicilatov in antioksidantov pri fototerapiji koĹľnih in/ali sklepnih obolenj
ES03815354T ES2351971T3 (es) 2003-01-17 2003-12-23 Uso de una combinación de sustancias de la síntesis de la porfirina, salicilatos y antioxidantes en la fototerapia de enfermedades de la piel y/o de las articulaciones.
AT03815354T ATE479431T1 (de) 2003-01-17 2003-12-23 Verwendung einer kombination von substanzen der porphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen
DE50313052T DE50313052D1 (de) 2003-01-17 2003-12-23 Rphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen
PCT/DE2003/004254 WO2004064827A1 (de) 2003-01-17 2003-12-23 Verwendung von substanzen der porphyrinsynthese für die anwendung in der phototherapie sowie zur behandlung von haut- und/oder gelenkerkrankungen
DK03815354.0T DK1583525T3 (da) 2003-01-17 2003-12-23 Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme
JP2004566721A JP2006514072A (ja) 2003-01-17 2003-12-23 光線療法における適用のための、並びに皮膚及び／又は関節疾患の処置のためのポルフィリン合成の物質の使用
CY20101101103T CY1110957T1 (el) 2003-01-17 2010-12-01 Χρηση ουσιων της συνθεσης πορφυρινης σε συνδυασμο με σαλικυλικα και αντιοξειδωτικα για την εφαρμογη στην φωτοθεραπεια για την αγωγη δερματικων ασθενειων και/ή ασθενειων των αρθρωσεων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10301917A DE10301917B4 (de) 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren

Publications (2)

Publication Number Publication Date
DE10301917A1 DE10301917A1 (de) 2004-07-29
DE10301917B4 true DE10301917B4 (de) 2007-02-01

Family

ID=32602752

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10301917A Expired - Fee Related DE10301917B4 (de) 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
DE50313052T Expired - Lifetime DE50313052D1 (de) 2003-01-17 2003-12-23 Rphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50313052T Expired - Lifetime DE50313052D1 (de) 2003-01-17 2003-12-23 Rphyrinsynthese, salicylaten und antioxidantien bei der phototherapie von haut- und/oder gelenkerkrankungen

Country Status (13)

Country Link
US (1) US20070099878A1 (enExample)
EP (1) EP1583525B1 (enExample)
JP (1) JP2006514072A (enExample)
AT (1) ATE479431T1 (enExample)
AU (1) AU2003300499A1 (enExample)
CY (1) CY1110957T1 (enExample)
DE (2) DE10301917B4 (enExample)
DK (1) DK1583525T3 (enExample)
ES (1) ES2351971T3 (enExample)
PT (1) PT1583525E (enExample)
RU (1) RU2336078C2 (enExample)
SI (1) SI1583525T1 (enExample)
WO (1) WO2004064827A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
DE102011117364A1 (de) * 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
DE202013003573U1 (de) 2013-04-16 2013-06-04 Gerhard Saalmann Ganzkörper-Belichtungseinheit
RU2712806C1 (ru) * 2019-05-20 2020-01-31 Федеральное государственное бюджетное учреждение "Государственный научный центр лазерной медицины имени О.К. Скобелкина Федерального медико-биологического агентства" Способ лечения больных перипротезной инфекцией после эндопротезирования сустава

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
DE4440112A1 (de) * 1994-11-11 1996-05-15 Jan H Dr Wilkens Bestrahlungsanordnung zur Behandlung von Hauterkrankungen
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
US5530157A (en) * 1995-02-16 1996-06-25 Scios Nova Inc. Anti-inflammatory benzoic acid derivatives
US5942534A (en) * 1996-10-10 1999-08-24 The General Hospital Corporation Photodynamic therapy for the treatment of osteoarthritis
RU2145247C1 (ru) * 1998-04-10 2000-02-10 Жаров Владимир Павлович Фотоматричное терапевтическое устройство для лечения протяженных патологий
WO2000002491A1 (en) * 1998-07-09 2000-01-20 Curelight Ltd. Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
ES2243549T3 (es) * 2000-09-08 2005-12-01 Vivier Canada Inc. Soluciones de acido ascorbico estabilizadas.
DE10063076A1 (de) * 2000-12-18 2002-06-27 Medac Klinische Spezialpraep Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe
US20030082101A1 (en) * 2001-06-11 2003-05-01 Cavalier Discovery Accelerators for increasing the rate of formation of free radicals and reactive oxygen species
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
DE4440112A1 (de) * 1994-11-11 1996-05-15 Jan H Dr Wilkens Bestrahlungsanordnung zur Behandlung von Hauterkrankungen
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln

Also Published As

Publication number Publication date
DE10301917A1 (de) 2004-07-29
ES2351971T3 (es) 2011-02-14
RU2005127035A (ru) 2006-01-27
DE50313052D1 (de) 2010-10-14
SI1583525T1 (sl) 2011-01-31
DK1583525T3 (da) 2011-01-03
EP1583525A1 (de) 2005-10-12
ATE479431T1 (de) 2010-09-15
JP2006514072A (ja) 2006-04-27
PT1583525E (pt) 2010-12-07
RU2336078C2 (ru) 2008-10-20
EP1583525B1 (de) 2010-09-01
WO2004064827A1 (de) 2004-08-05
US20070099878A1 (en) 2007-05-03
CY1110957T1 (el) 2015-06-11
AU2003300499A1 (en) 2004-08-13

Similar Documents

Publication Publication Date Title
EP0267321B1 (de) Ibuprofen enthaltendes Arzneimittel
DE69434218T2 (de) Photodynamische behandlung von synovium
DE69737144T2 (de) Antimikrobielle behandlung von herpes simplex viren und anderer infektioser erkrankungen
DE3413052A1 (de) Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen
DE69027220T2 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE10197266T5 (de) Verfahren zur örtlichen Betäubung und Schmerzstillung
WO1998046235A1 (de) Analgetika-kombination
DE68926115T2 (de) Verfahren zur behandlung von akne
DE3390116C2 (de) Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
DE60132008T2 (de) Cetylmyristat und cetylpalmitat zur behandlung von ekzemen und/oder psoriasis
EP0552657A1 (de) Verwendung von reiner Boswelliasäure
EP0037488A2 (de) Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen
DE2425988A1 (de) Medikament zur bekaempfung von erregungsund angstsyndromen
DE10301917B4 (de) Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
DE3344173C2 (de) Verwendung von alkanoyl-l-carnitin zur behandlung von myopathien oder muskulaeren dystrophien
DE3724691A1 (de) Pharmazeutisches mittel zur lokalen therapie der psoriasis
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DD242749A5 (de) Verbesserte entzuendungshemmende zusammensetzungen und verfahren
EP1019037B9 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
EP2620146A1 (de) Ibuprofen zur Behandlung von aktinischer Keratose
DE19629802A1 (de) Arzneimittel zur Behandlung von Neuropathien
AT504040B1 (de) Diclofenac-hältige zubereitung zur behandlung von verbrennungen
EP1131101B1 (de) Khellin-zubereitung und deren verwendung zur topischen therapie
EP1492546B1 (de) Verwendung von pyrimidinnukleotiden zur behandlung von schaedigungen des peripheren nervensystems
DE60210804T2 (de) Verwendung von propionyl-l-carnitin oder dessen pharmakologisch akzeptabler salze zur herstellung eines medikamentes zur behandlung von la peyronie's krankheit

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MEDLIGHT GMBH, 32051 HERFORD, DE

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee